Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® HCV / Hepatitis specialty page provides HCV / hepatitis-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


Treating HCV in HIV-Coinfection: Still a Therapeutic Dilemma?
Despite the availability of highly active agents against HCV, HIV-infected patients require special considerations for drug interactions when considering treatment options.  
The Challenge of Eliminating Hepatitis C Virus in the United States
The ambitious goal of global elimination of the virus by 2030 will take buy-in from all major stakeholders, including the United States.
ID Week 2017 Closing Plenary Provides Guarded Optimism for Coming Decades
Thoughts leaders believe infectious disease treatment is in the middle of a sea change, moving from antibiotics to antibodies.
Can Drinking Coffee Boost Survival Rates Among HIV/HCV Co-Infected Patients?
The results of a 5-year study show that coffee drinking can cut down the risk of all-cause mortality in patients with HIV and hepatitis C virus (HCV) infections.
<i>Contagion</i>® to Report on ID Week 2017 in San Diego
Contagion® will be providing exclusive coverage on the conference, and so, keep your eyes peeled for session coverage and interviews with some of the key presenters.
Sofosbuvir Found to Be Safe, Effective in Patients with Chronic Kidney Disease
A new study reveals that direct-acting antivirals, like sofosbuvir, may help improve kidney function in some patients.
Elbasvir & Grazoprevir Highly Efficacious in HCV Patients with Inherited Blood Disorders
Phase 3 study shows that combination of elbasvir and grazoprevir is highly efficacious in hepatitis C virus (HCV) infected patients with inherited blood disorders.
A Cost-Effective Method to Decrease HCV Infections in High-Risk Communities
Routine, rapid hepatitis C virus (HCV) testing may be a cost-effective method to help decrease the prevalence of new infections in high-risk communities.
Influenza A (H3N2) has caused most of the illnesses in this severe flu season, but influenza B is becoming increasingly responsible for more infections as the flu season continues to hit the United States.